BioCentury
ARTICLE | Financial News

Wilson's disease play secures $40 million

April 16, 2014 11:44 PM UTC

Wilson Therapeutics AB (Stockholm, Sweden) raised an undisclosed amount in a tranched $40 million series B round co-led by new investors Abingworth and MVM Life Science Partners. Existing investor Hea...